- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Germany Becomes Ninth European Nation to Legalize Recreational Cannabis
In a landmark decision, Germany has become the ninth European nation to legalize recreational cannabis, marking a potential shift in the continent's approach to the drug.
Germany has approved a bill that would legalize the recreational use and possession of cannabis for adults over the age of 18 as of April 1, 2024, becoming the latest European nation to do so.
The matter was taken to a vote on Friday (February 23) morning in the Bundestag, Germany’s parliament. The debate was reportedly heated, but in the end the measure passed with 407 votes for and 226 against.
Under the new law, German adults will be able to legally possess up to 25 grams of cannabis in public places and 50 grams at home. Smoking cannabis in public will also be allowed, as will home cultivation of up to three plants.
Medical use of cannabis has been legal in Germany since 2017.
Health Minister Karl Lauterbach, a vocal advocate for the legal recreational use of cannabis, pointed out that the use of cannabis has increased despite its current illegal status, doubling in the past 10 years.
He hopes that the passing of this law will undermine the illicit sale of cannabis by criminal organizations and reduce the risk of smokers being exposed to other substances from contaminated plants.
The news has been met with opposition from German healthcare professionals and conservative politicians who worry that legalization will fuel the use of other drugs. Some members of the Christian Democratic Union, Germany’s conservative party, have said that they will repeal the law if they regain power after the next election.
Previously discussed plans to allow licensed shops and pharmacies to supply cannabis were shelved in favor of non-commercial “cannabis social clubs.” These clubs, which will open on July 1, 2024, will have a member limit of 500, and memberships will only be granted to German citizens; tourists will not be allowed to consume cannabis in the clubs or purchase cannabis from them. Critics say these paradoxical guidelines may increase illicit activity, since occasional smokers may have a difficult time obtaining cannabis legally and because the law prohibits tourists from using the clubs.
Official documents, including statements from supporters and opposers written in German, can be found here.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
- 5 Biggest Cannabis ETFs in 2023 ›
- Cannabis Stocks: 10 Biggest Companies ›
- Cannabis Market 2023 Year-End Review ›
- Cannabis Market Forecast: Top Trends That Will Affect Cannabis in 2024 ›
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Learn about our editorial policies.